ATE430937T1 - Plasma urotensin und menschliche herzerkrankung - Google Patents

Plasma urotensin und menschliche herzerkrankung

Info

Publication number
ATE430937T1
ATE430937T1 AT03740791T AT03740791T ATE430937T1 AT E430937 T1 ATE430937 T1 AT E430937T1 AT 03740791 T AT03740791 T AT 03740791T AT 03740791 T AT03740791 T AT 03740791T AT E430937 T1 ATE430937 T1 AT E430937T1
Authority
AT
Austria
Prior art keywords
heart disease
human heart
urotensin
plasma
plasma urotensin
Prior art date
Application number
AT03740791T
Other languages
English (en)
Inventor
Leong Ng
Original Assignee
Inverness Medical Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216505A external-priority patent/GB0216505D0/en
Application filed by Inverness Medical Switzerland filed Critical Inverness Medical Switzerland
Application granted granted Critical
Publication of ATE430937T1 publication Critical patent/ATE430937T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5751—Corticotropin releasing factor [CRF] (Urotensin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03740791T 2002-07-11 2003-07-11 Plasma urotensin und menschliche herzerkrankung ATE430937T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0216191.7A GB0216191D0 (en) 2002-07-11 2002-07-11 Plasma urotensin in human heart failure
GBGB0216500.9A GB0216500D0 (en) 2002-07-11 2002-07-16 Plasma urotensin in human heart failure
GB0216505A GB0216505D0 (en) 2002-07-11 2002-07-17 Plasma urotensin in human heart failure
PCT/GB2003/003011 WO2004008140A2 (en) 2002-07-11 2003-07-11 Plasma urotensin in human heart failure

Publications (1)

Publication Number Publication Date
ATE430937T1 true ATE430937T1 (de) 2009-05-15

Family

ID=9940317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740791T ATE430937T1 (de) 2002-07-11 2003-07-11 Plasma urotensin und menschliche herzerkrankung

Country Status (11)

Country Link
US (1) US20040077027A1 (de)
EP (1) EP1521967B1 (de)
JP (1) JP4602078B2 (de)
CN (1) CN100582782C (de)
AT (1) ATE430937T1 (de)
AU (1) AU2003281071B2 (de)
CA (1) CA2492787A1 (de)
DE (1) DE60327530D1 (de)
GB (2) GB0216191D0 (de)
IL (2) IL166194A0 (de)
WO (1) WO2004008140A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
US20090054741A1 (en) * 2005-03-29 2009-02-26 Inverness Medical Switzerland Gmbh Device and method of monitoring a patient
EP1722232A1 (de) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion
EP1910843A2 (de) * 2005-07-11 2008-04-16 Inverness Medical Switzerland GmbH Assay
JP2010517023A (ja) * 2007-01-25 2010-05-20 エフ．ホフマン−ラ ロシュ アーゲー 心不全の評価におけるｉｇｆｂｐ−７の使用
EP2145184B1 (de) * 2007-03-08 2013-10-02 Roche Diagnostics GmbH Verwendung von slim-1 bei der beurteilung von herzversagen
CA2738417A1 (en) * 2008-10-17 2010-04-22 F. Hoffmann-La Roche Ag Use of biglycan in the assessment of heart failure
WO2015175502A2 (en) * 2014-05-12 2015-11-19 Palatin Technologies, Inc. Replacement therapy for natriuretic peptide deficiencies
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710008B1 (en) * 1990-10-12 1999-09-07 Spectral Diagnostics Inc Method and device for diagnosing and distinguishing chest pain in early onset thereof
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
AU7590198A (en) * 1997-06-10 1998-12-30 Medlyte Diagnostics, Inc. Methods for early detection of heart disease
WO1999035266A2 (en) * 1998-01-09 1999-07-15 Smithkline Beecham Corporation Human urotensin ii
US6075137A (en) * 1998-01-09 2000-06-13 Smithkline Beecham Corporation Human urotensin II
DE50015291D1 (de) * 1999-01-29 2008-09-11 Roche Diagnostics Gmbh Verfahren zum Nachweis von N-terminalem proBNP
EP1241479B1 (de) * 2001-03-12 2007-08-01 Immundiagnostik AG Verfahren zur Bestimmung von Urotensin II in Körperflüssigkeiten und Diagnose von kardiovaskulären Krankheiten

Also Published As

Publication number Publication date
JP2005532564A (ja) 2005-10-27
AU2003281071A1 (en) 2004-02-02
CN100582782C (zh) 2010-01-20
GB0216500D0 (en) 2002-08-28
IL166194A0 (en) 2006-01-15
EP1521967A2 (de) 2005-04-13
US20040077027A1 (en) 2004-04-22
WO2004008140A2 (en) 2004-01-22
CA2492787A1 (en) 2004-01-22
EP1521967B1 (de) 2009-05-06
DE60327530D1 (de) 2009-06-18
JP4602078B2 (ja) 2010-12-22
IL166194A (en) 2010-11-30
WO2004008140A3 (en) 2004-05-06
CN1678912A (zh) 2005-10-05
AU2003281071B2 (en) 2007-12-13
GB0216191D0 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
IL166194A (en) Plasma urotensin in human heart failure
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
DE602005021505D1 (de) Verfahren und system zur überwachung von beatmungen
WO2007072225A3 (en) Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
ATE365165T1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
FI20021145A (fi) Laitteisto elintoimintojen mittaamiseksi
NO20050569D0 (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
DE60326214D1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
DE60302995D1 (de) Blutdruckmessgerät
EP2503338A3 (de) CD73 als Biomarker zur Überwachung der Entwicklung von Krankheiten und zum Testen der Wirksamkeit von Therapien
FI20030547A0 (fi) Menetelmä ja järjestelmä sydänanalyysiä varten
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
DE50200029D1 (de) Medizinisches Instrument zum Spülen und/oder Saugen
ITMI20030897A1 (it) Procedimento e apparecchiatura per frazionare sangue.
AU2003212246A8 (en) Method for diagnosis of inflammatory diseases using mrp8/mrp14
ITMI20021377A0 (it) Interfaccia ostointegrativa per protesi impiantabili e metodo per il trattamento di detta interfaccia ostointegrativa
WO2007060647A3 (en) A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels
GB0217333D0 (en) System and method for solution based multiparameter analysis of analytes
AU2003223033A8 (en) System for point of care diagnosis and/or analysis
EP1540353A4 (de) Teststreifen und verfahren zur bestimmung der ldl-cholesterinkonzentration aus vollblut
EP1492880A4 (de) Ex-vivo-verfahren zur bestimmung der cetp-aktivität und der wirksamkeit der behandlung von herzerkrankungen
ATE483983T1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
AU2003299389A8 (en) PRP detection method using an aminoglycoside antibiotic
WO2002053769A3 (de) Dna-chip zur kausalen diagnose von bluthochdruck

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties